Press Releases
Osteoarthritis Biomarkers Project May Lead to Better Quality of Life for Those with Osteoarthritis
The Foundation for the National Institutes of Health (FNIH) announces the launch of a new research study designed to improve clinical outcomes for those living with osteoarthritis (OA) of the knee or who are at risk of developing the disease...
New Project Led by the Foundation for the NIH Biomarkers Consortium Will Have Significant Impact On the Development of New Antibiotics
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a research collaboration that aims to remove obstacles to developing new antibacterial treatments for common, serious skin infections and community-acquired bacterial pneumonia, or CABP…
The FNIH Biomarkers Consortium Announces Availability of Alzheimer’s Disease Biomarker Data
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium today announced the release of biomarker data from studies intended to improve our ability to diagnose and measure the progression of Alzheimer’s disease (AD) …
Foundation for the NIH Launches Trial to Develop
Diabetes Diagnostic Tools
The Biomarkers Consortium Announced Today Multi-year Clinical Study to Improve Tools for Measuring the Function of Insulin-producing Beta Cells in People with Type 2 diabetes Mellitus Bethesda, MD (May 10, 2011) — The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium announced today …
The Biomarkers Consortium Announces Availability of Alzheimer’s Disease Plasma Proteomics Data
The Biomarkers Consortium The Biomarkers Consortium Announces Availability of Alzheimer’s Disease Plasma Proteomics Data Bethesda, MD (December 7, 2010) — The Foundation for the National Institutes of Health’s Biomarkers …
The Biomarkers Consortium Completes First Project to Show that Adiponectin is a Predictive Biomarker for Type 2 Diabetes
The Biomarkers Consortium Adiponectin is a Predictive Biomarker for Type 2 Diabetes … and easy to measure through commercially available kits, was confirmed as a robust biomarker predictive …
The Biomarkers Consortium Launches I-SPY 2 Breast Cancer Clinical Trial
The Biomarkers Consortium The Biomarkers Consortium Launches I-SPY 2 Breast Cancer Clinical Trial The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug …
Foundation for NIH Announces Renewal of the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
… imaging techniques and biomarker measures in blood and cerebrospinal fluid. "The study’s chief goal is to identify biomarkers that recognize Alzheimer’s disease at an early stage and monitor progression … to see in the living brain and identifying biomarkers that signal brain changes is revolutionizing …
